LFWD
Lifeward Ltd.
LFWD offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
OSCR
Oscar Health, Inc.
OSCR has the edge over LFWD overall, supported by stronger fundamentals and lower modeled downside.
LFWD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
LFWD's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
LFWD PE Valuation
LFWD has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
LFWD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect LFWD's losses to shrink, with revenue growing.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
LFWD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$17.23 | +$20.45 |
| Q1 2026 | -$20.07 | +$16.65 |
| Q4 2025 | -$18.89 | +$21.07 |
| Q3 2025 | -$35.88 | -$9.36 |
| Q2 2025 | -$37.68 | -$4.44 |
| Q1 2025 | -$36.72 | -$2.76 |
| Q4 2024 | -$39.96 | -$8.88 |
| Q3 2024 | -$26.52 | +$3.72 |
LFWD is still losing money, but far less than before: $17.23 per share over the past year, against $364.56 at its worst in late 2019.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over LFWD on earnings quality, reporting a profit while its opponent remains loss making.
LFWD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6M | +16% |
| Q1 2026 | $3.9M | -22% |
| Q4 2025 | $5.1M | -33% |
| Q3 2025 | $6.2M | +1.1% |
| Q2 2025 | $5.7M | -15% |
| Q1 2025 | $5M | -4.7% |
| Q4 2024 | $7.5M | +9.6% |
| Q3 2024 | $6.1M | +39% |
LFWD's revenue is down over the past year, though its latest quarter was up: $7M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -63% | +52 points |
| Q1 2026 | -264% | -167 points |
| Q4 2025 | -101% | +101 points |
| Q3 2025 | -51% | +1.1 points |
| Q2 2025 | -115% | -48 points |
| Q1 2025 | -96% | +27 points |
| Q4 2024 | -202% | -113 points |
| Q3 2024 | -52% | +129 points |
LFWD's operating margin was −63% last quarter, up 52 points from the same quarter a year ago.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over LFWD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over LFWD on profitability, with a higher operating margin.
LFWD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6M | -$2.1M |
| Q1 2026 | -$3.7M | +$1.8M |
| Q4 2025 | -$3.6M | +$403K |
| Q2 2025 | -$3.9M | +$1.7M |
| Q1 2025 | -$5.5M | +$2.2M |
| Q4 2024 | -$4M | +$594K |
| Q2 2024 | -$5.6M | -$2.1M |
| Q1 2024 | -$7.7M | -$2.4M |
LFWD has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over LFWD on cash generation, producing positive trailing cash flow while its opponent burns cash.
LFWD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +74% | +1.2M shares |
| 1 year | +220% | +1.9M shares |
| 3 years | +295% | +2.1M shares |
| 5 years | +1144% | +2.6M shares |
LFWD has 3M diluted shares, up 220% from a year ago.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over LFWD on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LFWD Net Leverage
LFWD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
LFWD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 22.9 | Neutral |
LFWD's weekly RSI is 39 (neutral) and its Stochastic is 23 (neutral).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
LFWD PE vs Healthcare Sector
LFWD has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
LFWD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.11 | 6.4% below |
| 20 week MA | $6.92 | 17% below |
| 50 week MA | $7.03 | 19% below |
| 100 week MA | $10.4 | 45% below |
| 200 week MA | $32.9 | 83% below |
LFWD is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over LFWD on trend strength, trading above more of its moving averages.
LFWD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $186.5 | $136.1 | -27% |
| 2021 | $136.1 | $113.4 | -17% |
| 2022 | $113.4 | $65.5 | -42% |
| 2023 | $65.5 | $65.4 | -0.2% |
| 2024 | $65.4 | $24.1 | -63% |
| 2025 | $24.1 | $7.73 | -68% |
| 2026 YTD | $7.73 | $5.72 | -26% |
LFWD has finished every year since 2020 lower, and it's down 26% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over LFWD on returns for 2026, with the stronger performance.